RAMZI GHOSN: Open Payments
NPI 1407943301 · DAWSONVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,359 in 62 payments from 21 companies in 2025. Trend: 2023 $1,583 · 2024 $1,543 · 2025 $1,359
Food & beverage: $1,359
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 3 | $163 |
| PFIZER INC. | 8 | $152 |
| Amgen Inc. | 9 | $149 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $112 |
| Vanda Pharmaceuticals Inc. | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 4 | $96 |
| Novo Nordisk Inc | 3 | $57 |
| Lundbeck LLC | 2 | $57 |
| ABBVIE INC. | 3 | $55 |
| Axsome Therapeutics, Inc. | 2 | $52 |
Products named: REXULTI, OTEZLA, INTELLIS ADAPTIVESTIM, CAPLYTA, NURTEC ODT, FANAPT, SUBLOCADE, XIFAXAN.
Industry payments across GA — which companies pay providers there.
